{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:49:19Z","timestamp":1792093759055,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ophtha.2026.10.009","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:23:22Z","timestamp":1792020202000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Second and Third Decade After 103Pd Plaque Brachytherapy for Choroidal Melanoma"],"prefix":"10.1016","author":[{"given":"Margarita","family":"Labkovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2026.10.009_bib1","first-page":"1","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ophtha.2026.10.009_bib2","doi-asserted-by":"crossref","unstructured":"Maheshwari A, Finger PT. Patient counseling in ocular oncology. In: Finger PT, ed. Finger\u2019s Essential Ophthalmic Oncology: Principles and Practice. Kugler Publications; 2025:91-100. doi:10.35119\/4220ec90","DOI":"10.35119\/4220ec90"},{"issue":"5","key":"10.1016\/j.ophtha.2026.10.009_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0161-6420(92)31899-8","article-title":"Long-term results of iodine 125 irradiation of uveal melanoma","volume":"99","author":"Packer","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.10.009_bib4","first-page":"2197","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. IV. Local treatment failure and enucleation in the first 5 years after brachytherapy","volume":"109","author":"Jampol","year":"2002","journal-title":"COMS Report No. 19. Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.10.009_bib5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ophtha.2008.12.027","article-title":"Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients","volume":"116","author":"Finger","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.10.009_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.754108","article-title":"Long-term outcomes in uveal melanoma after ruthenium-106 brachytherapy","volume":"11","author":"Cennamo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.10.009_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcjo.2026.04.006","article-title":"Thirty-year visual acuity outcomes after plaque brachytherapy for posterior uveal melanoma","author":"Dalvin","year":"2026","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib9","unstructured":"Sun V, Tomar AS, Finger PT. Overview of ophthalmic clinical examination. In: Finger PT, ed. Finger\u2019s Essential Ophthalmic Oncology: Principles and Practice. Kugler Publications; 2025:27-36"},{"key":"10.1016\/j.ophtha.2026.10.009_bib10","doi-asserted-by":"crossref","unstructured":"Finger PT. Finger\u2019s methods for ophthalmic plaque surgery. In: Finger PT, ed. Finger\u2019s Essential Ophthalmic Oncology: Principles and Practice. Kugler Publications; 2025:355-372. https:\/\/kugler.pub\/publication\/fingers-essential-ophthalmic-oncology\/","DOI":"10.35119\/4220ec90"},{"key":"10.1016\/j.ophtha.2026.10.009_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5301\/ejo.5000049","article-title":"Initial PET\/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients","volume":"22","author":"Freton","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib12","unstructured":"Amin MB, Edge SB, Greene FL, et al, eds. AJCC Cancer Staging Manual. 8th ed. Springer; 2017"},{"key":"10.1016\/j.ophtha.2026.10.009_bib13","doi-asserted-by":"crossref","unstructured":"Semenova ES, Finger PT. Screening for uveal melanoma metastasis. In: Finger PT, ed. Finger\u2019s Essential Ophthalmic Oncology: Principles and Practice. Kugler Publications; 2025:374-384. https:\/\/kugler.pub\/publication\/fingers-essential-ophthalmic-oncology\/","DOI":"10.35119\/4220ec90"},{"key":"10.1016\/j.ophtha.2026.10.009_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bjo.2007.114082","article-title":"Finger\u2019s \u201cslotted\u201d eye plaque for radiation therapy: treatment of juxtapapillary and circumpapillary intraocular tumours","volume":"91","author":"Finger","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archopht.125.9.1202","article-title":"Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma)","volume":"125","author":"Sagoo","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archopht.125.6.751","article-title":"Anti-vascular endothelial growth factor bevacizumab for radiation retinopathy","volume":"125","author":"Finger","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41433-022-02200-5","article-title":"Early anti-VEGF treatment for radiation maculopathy and optic neuropathy: lessons learned","volume":"37","author":"Powell","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2026.10.009_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5301\/ejo.5000670","article-title":"Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study","volume":"26","author":"Finger","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.oret.2020.01.010","article-title":"Anti-VEGF therapy immediately after plaque radiation therapy prevents or delays radiation maculopathy","volume":"4","author":"Powell","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"10.1016\/j.ophtha.2026.10.009_bib20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjo.2004.052159","article-title":"Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy","volume":"89","author":"Finger","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2026.10.009_bib21","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1136\/bjophthalmol-2017-310315","article-title":"Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab","volume":"101","author":"Kaplan","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.10.009_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcjo.2025.09.017","article-title":"Intravitreal fluocinolone acetonide 0.19 mg Iluvien implant for radiation maculopathy","volume":"61","author":"Finger","year":"2026","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ajo.2018.01.025","article-title":"A 12-year study of slotted palladium-103 plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve","volume":"188","author":"Maheshwari","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2026.10.009_bib24","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.ophtha.2014.05.037","article-title":"Extraocular muscle repositioning and diplopia: associated with ophthalmic plaque radiation therapy for choroidal melanoma","volume":"121","author":"Nagendran","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.10.009_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archophthalmol.2007.9","article-title":"Tilting of radioactive plaques after initial accurate placement for treatment of uveal melanoma","volume":"126","author":"Almony","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.10.009_bib26","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of iodine-125 and palladium-103 COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ophtha.2026.10.009_bib27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ajo.2009.11.006","article-title":"Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma","volume":"149","author":"Finger","year":"2010","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026007797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026007797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:25:41Z","timestamp":1792092341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026007797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S0161642026007797"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.10.009","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Second and Third Decade After 103Pd Plaque Brachytherapy for Choroidal Melanoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}